SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001214659-18-005321
Filing Date
2018-08-09
Accepted
2018-08-09 16:25:52
Documents
51
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 h73118010q.htm 10-Q 338639
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 39825
3 EXHIBIT 31.1 ex31_1.htm EX-31.1 8125
4 EXHIBIT 31.2 ex31_2.htm EX-31.2 8189
5 EXHIBIT 32.1 ex32_1.htm EX-32.1 4772
6 EXHIBIT 32.2 ex32_2.htm EX-32.2 4111
  Complete submission text file 0001214659-18-005321.txt   2377885

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE hgen-20180630.xml EX-101.INS 337946
8 XBRL SCHEMA FILE hgen-20180630.xsd EX-101.SCH 35550
9 XBRL CALCULATION FILE hgen-20180630_cal.xml EX-101.CAL 38812
10 XBRL DEFINITION FILE hgen-20180630_def.xml EX-101.DEF 120573
11 XBRL LABEL FILE hgen-20180630_lab.xml EX-101.LAB 264790
12 XBRL PRESENTATION FILE hgen-20180630_pre.xml EX-101.PRE 189779
Mailing Address 533 AIRPORT BLVD. SUITE 200 BURLINGAME CA 94010
Business Address 533 AIRPORT BLVD. SUITE 200 BURLINGAME CA 94010 650.243.3100
HUMANIGEN, INC (Filer) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35798 | Film No.: 181005427
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences